Posted by Michael Wonder on 09 Apr 2020
NICE publishes new COVID-19 guidelines on cystic fibrosis, chronic obstructive pulmonary disease and dermatological conditions treated with drugs affecting the immune response
9 April 2020 - NICE has today published 3 new rapid guidelines on the care of patients with suspected and confirmed COVID-19, and in patients without COVID-19.
The guidelines have been designed to maximise the safety of patients whilst enabling services to make the best use of NHS resources.
They cover the care of patients with cystic fibrosis, chronic pulmonary obstructive disease and dermatological conditions treated with drugs affecting the immune response.
